J T W Wigman1, J van Os1, L Abidi1, M J H Huibers2, J Roelofs2, A Arntz2, I Kelleher3, F P M L Peeters1. 1. Department of Psychiatry and Psychology, School of Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, The Netherlands. 2. Department of Clinical Psychological Science, Research Institute of Experimental Psychopathology, Faculty of Psychology and Neuroscience, Maastricht University, The Netherlands. 3. Department of Psychiatry, Royal College of Surgeons in Ireland, Education and Research Centre, Beaumont Hospital, Dublin, Republic of Ireland.
Abstract
BACKGROUND: Subthreshold psychotic and bipolar experiences are common in major depressive disorder (MDD). However, it is unknown if effectiveness of psychotherapy is altered in depressed patients who display such features compared with those without. The current paper aimed to investigate the impact of the co-presence of subclinical psychotic experiences and subclinical bipolar symptoms on the effectiveness of psychological treatment, alone or in combination with pharmacotherapy. METHOD: In a naturalistic study, patients with MDD (n = 116) received psychological treatment (cognitive behavioural therapy or interpersonal psychotherapy) alone or in combination with pharmacotherapy. Depression and functioning were assessed six times over 2 years. Lifetime psychotic experiences and bipolar symptoms were assessed at the second time point. RESULTS: Subclinical psychotic experiences predicted more depression over time (β = 0.20, p < 0.002), non-remission [odds ratio (OR) 7.51, p < 0.016] and relapse (OR 3.85, p < 0.034). Subthreshold bipolar symptoms predicted relapse (OR 1.16, p < 0.037). CONCLUSIONS: In general, subclinical psychotic experiences have a negative impact on the course and outcome of psychotherapy in MDD. Effects of subclinical bipolar experiences were less prominent.
BACKGROUND: Subthreshold psychotic and bipolar experiences are common in major depressive disorder (MDD). However, it is unknown if effectiveness of psychotherapy is altered in depressedpatients who display such features compared with those without. The current paper aimed to investigate the impact of the co-presence of subclinical psychotic experiences and subclinical bipolar symptoms on the effectiveness of psychological treatment, alone or in combination with pharmacotherapy. METHOD: In a naturalistic study, patients with MDD (n = 116) received psychological treatment (cognitive behavioural therapy or interpersonal psychotherapy) alone or in combination with pharmacotherapy. Depression and functioning were assessed six times over 2 years. Lifetime psychotic experiences and bipolar symptoms were assessed at the second time point. RESULTS: Subclinical psychotic experiences predicted more depression over time (β = 0.20, p < 0.002), non-remission [odds ratio (OR) 7.51, p < 0.016] and relapse (OR 3.85, p < 0.034). Subthreshold bipolar symptoms predicted relapse (OR 1.16, p < 0.037). CONCLUSIONS: In general, subclinical psychotic experiences have a negative impact on the course and outcome of psychotherapy in MDD. Effects of subclinical bipolar experiences were less prominent.
Authors: Lotta-Katrin Pries; Sinan Guloksuz; Margreet Ten Have; Ron de Graaf; Saskia van Dorsselaer; Nicole Gunther; Christian Rauschenberg; Ulrich Reininghaus; Rajiv Radhakrishnan; Maarten Bak; Bart P F Rutten; Jim van Os Journal: Schizophr Bull Date: 2018-06-06 Impact factor: 9.306
Authors: Álvaro I Langer; Klaas Wardenaar; Johanna T W Wigman; José Luis Ulloa; Daniel Núñez Journal: Front Psychiatry Date: 2022-06-27 Impact factor: 5.435
Authors: Johanna T W Wigman; Stijn de Vos; Marieke Wichers; Jim van Os; Agna A Bartels-Velthuis Journal: Schizophr Bull Date: 2016-07-06 Impact factor: 9.306
Authors: Sinan Guloksuz; Martine van Nierop; Maarten Bak; Ron de Graaf; Margreet Ten Have; Saskia van Dorsselaer; Nicole Gunther; Roselind Lieb; Ruud van Winkel; Hans-Ulrich Wittchen; Jim van Os Journal: BMC Psychiatry Date: 2016-07-08 Impact factor: 3.630
Authors: Sanne H Booij; Marieke Wichers; Peter de Jonge; Sjoerd Sytema; Jim van Os; Lex Wunderink; Johanna T W Wigman Journal: BMJ Open Date: 2018-01-21 Impact factor: 2.692
Authors: Steven Honings; Marjan Drukker; Margreet Ten Have; Ron de Graaf; Saskia van Dorsselaer; Jim van Os Journal: PLoS One Date: 2016-07-22 Impact factor: 3.240
Authors: Steven Honings; Marjan Drukker; Margreet Ten Have; Ron de Graaf; Saskia van Dorsselaer; Jim van Os Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2017-08-31 Impact factor: 4.328